![Jason Lettmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Lettmann
Chief Executive Officer at
ALX ONCOLOGY HOLDINGS INC.
Net worth: 545 671 $ as of 30/06/2026
Profile
Jason Lettmann is the founder of Tarsus Medical, Inc., founded in 2009, where the title held was Director from 2009 to 2011.
Current jobs include Chief Executive Officer & Director at ALX Oncology, Inc. since 2015; Chief Executive Officer & Director at ALX Oncology Holdings, Inc. since 2023; Director at Relievant Medsystems, Inc.; Director at Second Genome, Inc.; Director at Foundry Innovation & Research 1 Ltd.; Director at Carrick Therapeutics, Inc.; Director at Cerevance, Inc.; Director at Atsena Therapeutics, Inc.; and Partner at Morgenthaler Management Corp.
since 2011.
Former jobs include Chief Executive Officer & Director at Promedior, Inc. from 2019 to 2020; Director at Vapotherm, Inc.; Independent Director at RA Pharmaceuticals, Inc. from 2015 to 2018; Director at ALX Oncology Ltd.; Principal at Guidant Corp.; Vice President at Split Rock Partners LLC from 2006 to 2009; Principal at Evalve, Inc.; Genetic Research Analyst at University of Iowa Hospitals & Clinics; Consultant at Accenture LLC; and General Partner at LSV Capital Management LLC from 2012 to 2023.
Education includes an undergraduate degree from the University of Iowa conferred in 1999 and an MBA from Stephen M.
Ross School of Business conferred in 2006.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 263,609 ( 0.2% ) | 545 671 $ | 30/06/2026 |
Jason Lettmann active positions
| Companies | Position | Start |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Chief Executive Officer | 06/09/2023 |
Atsena Therapeutics, Inc.
 Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness | Director/Board Member | - |
Cerevance, Inc.
 Cerevance, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Director/Board Member | - |
Carrick Therapeutics Ltd.
 Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for oncological therapy treatment | Director/Board Member | - |
Relievant Medsystems, Inc.
 Relievant Medsystems, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that provides diagnosing and treating chronic low back pain services | Director/Board Member | - |
Foundry Innovation & Research 1 Ltd.
 Foundry Innovation & Research 1 Ltd. Medical SpecialtiesHealth Technology Manufactures medical devices for heart failure patients | Director/Board Member | - |
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Develops microbiome-based therapeutic products | Director/Board Member | - |
Morgenthaler Management Corp.
 Morgenthaler Management Corp. Investment ManagersFinance Morgenthaler invests in companies located in the United State with an EBITDA of USD 8 - 40 million. The firm focuses on companies operating in the fields of information technology and life sciences sectors. It provides financing for early and later stage capital requirements. | Private Equity Investor | 20/01/2011 |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers | Chief Executive Officer | 01/09/2023 |
Former positions of Jason Lettmann
| Companies | Position | End |
|---|---|---|
| ░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Training of Jason Lettmann
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
80
1st degree connections
22
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 22 |
|---|---|
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
Vapotherm, Inc.
 Vapotherm, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets respiratory devices | Health Technology |
Split Rock Partners LLC
 Split Rock Partners LLC Investment ManagersFinance Split Rock Partners invests in companies located in the United States. The firm targets companies operating in the fields of healthcare, software and internet services. It participates in seed, early and growth capital requirements. | Finance |
Relievant Medsystems, Inc.
Relievant Medsystems, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that provides diagnosing and treating chronic low back pain services | Health Technology |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
Tarsus Medical, Inc.
 Tarsus Medical, Inc. Medical SpecialtiesHealth Technology Manufactures podiatry devices | Health Technology |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evalve, Inc.
 Evalve, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices | Health Technology |
University of Iowa Hospitals & Clinics
 University of Iowa Hospitals & Clinics Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Promedior, Inc.
 Promedior, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics to treat fibrotic diseases | Health Technology |
Morgenthaler Management Corp.
Morgenthaler Management Corp. Investment ManagersFinance Morgenthaler invests in companies located in the United State with an EBITDA of USD 8 - 40 million. The firm focuses on companies operating in the fields of information technology and life sciences sectors. It provides financing for early and later stage capital requirements. | Finance |
Accenture LLC
 Accenture LLC Miscellaneous Commercial ServicesCommercial Services Provides financial and investment services | Commercial Services |
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Develops microbiome-based therapeutic products | Health Technology |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Foundry Innovation & Research 1 Ltd.
Foundry Innovation & Research 1 Ltd. Medical SpecialtiesHealth Technology Manufactures medical devices for heart failure patients | Health Technology |
Alx Oncology Ltd.
 Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company developing immuno-oncology therapies for cancer | Health Technology |
Carrick Therapeutics Ltd.
Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for oncological therapy treatment | Health Technology |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Health Technology |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers | Health Technology |
Atsena Therapeutics, Inc.
Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness | Health Technology |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
- Stock Market
- Insiders
- Jason Lettmann
